PD01-10 EFFECTS OF REPEAT HYDRODISTENTION FOR INTERSTITIAL CYSTITIS

• DOI: 10.1016/j.juro.2017.02.190
• Publication Date: 2017-04-03T18:06:41Z
• Authors: Peter Kirk; Yahir Santiago-La...; John Stoffel; J Quentin Clemens; Anne Pelletier Ca...
• Keywords: 03 medical and health sciences; 0302 clinical medicine

You have accessJournal of UrologyInfections/Inflammation/Cystic Disease the Genitourinary Tract: Interstitial Cystitis I1 Apr 2017PD01-10 EFFECTS OF REPEAT HYDRODISTENTION FOR INTERSTITIAL CYSTITIS Peter Kirk, Yahir Santiago-Lastra, John Stoffel, J Quentin Clemens, and Anne Pelletier Cameron KirkPeter Kirk More articles by this author , Santiago-LastraYahir Santiago-Lastra StoffelJohn Stoffel ClemensJ Clemens CameronAnne View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.190AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Cystoscopy hydrodistention is a therapeutic procedure for interstitial cystitis (IC) which achieves symptomatic relief in many patients, though its use varies widely between providers. The long term effects repeated are not well understood it known if patients suffer reduction bladder capacity due these multiple procedures or develop ulcerating disease over time. We sought investigate hydrodistentions with IC. METHODS retrospectively queried our institutional records without ulcerative who underwent 2 more IC ten year period. Patient charts were reviewed demographic clinical factors at time diagnosis treatment. RESULTS There 97 cystoscopy non during study cohort was 98% female 92% Caucasian. Mean age 35.7 years, mean BMI 27.1. Average number performed 3.7 (range 18), 430.6 days. Within 63.3% had least 1 comorbid pain disorder. initial final anesthetic 723.9cc 753.1cc, respectively, significantly different (p=0.15). One patient later developed present cystoscopy. Among completed AUA symptom questionnaires before after hydrodistention, both quality life scores improved following treatment (17.1 vs 14.3, 4.3 3.6, p <0.001 both). complication rate period 0.83% comprised an extraperitoneal perforation managed conservatively, anaphylaxis DMSO instillation, transient tachycardia hypotension. CONCLUSIONS Repeated did decrease development ulceration rare. In significant positive on control life. Hydrodistention safe low rates. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e49-e50 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Expand PDF downloadLoading ...